Abemaciclib is a kinase inhibitor that exerts its therapeutic effect by selectively inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6).
Authentic
Guarantee
Fast Delivery
Privacy Common Side EffectsHematologic ToxicityNeutropenia may occur; regular complete blood count monitoring is required. Dose adjustment or treatment interr···【Read More】
Update: 06 Mar,2026Source: Haiou HealthViews: 69
Abemaciclib is an oral targeted anticancer drug belonging to the CDK4/6 inhibitor class. It is mainly used for the treatment of hormone receptor‑posit···【Read More】
Update: 06 Mar,2026Source: Haiou HealthViews: 73
Copyright2024@ BIGBEAR All right reserved BIGBEAR



